Novozymes blazes acquisition trail  

Novozymes acquires majority stake in Texas based InterBio

Novozymes, the world's leading enzyme producer, has announced that it has acquired the majority of the activities of InterBio, Texas, USA, for an undisclosed sum. InterBio is a company which, like Novozymes Biologicals, researches, produces and sells environmentally friendly products based on naturally occurring microorganisms. The acquisition means that the Danish company now has more than 50% of the growing market for industrial microorganisms.


"InterBio's activities are well matched to those of Novozymes Biologicals and we are now large enough to be able to invest in major research. At the same time, we are expanding our customer base not just in the USA, but also in Europe, where the use of microorganisms is now beginning to enjoy serious growth. InterBio's production activities can be integrated directly into Novozymes Biologicals and, as a result of the acquisition of George A. Jeffreys last month, we now have sufficiently large production capacity which we can utilize to the maximum," says Ted Melnik, President of Novozymes Biologicals.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×